Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia
Timothy Glidewell, Spatial Regional Account Manager at Bruker Spatial, reposted from The National Institutes of Health on LinkedIn:
”The latest NCI update on an experimental therapy for severe aplastic anemia is an important signal for anyone thinking about bone marrow failure, immune dysregulation, and why only some patients respond to treatment.
To truly unravel these questions, we need to see how stem/progenitor cells, stromal support cells, and immune effectors are organized and interacting in situ.
That’s where CosMx™ Spatial Molecular Imager can help—enabling single-cell, subcellular, whole-transcriptome views of rare cell populations within the marrow niche.
These insights can support translational teams working to understand mechanisms of response and resistance in severe, immune-mediated diseases.
If you’re in the Bay Area and would like to discuss how these spatial biology platforms could support your research, feel free to reach out!”
Quoting The National Institutes of Health‘s post:
”NEWS: An NIH clinical trial has shown promise for an experimental treatment for people with severe aplastic anemia, a life-threatening disorder with limited treatments.”
Read the full announcement here.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation